← Back to Clinical Trials
Recruiting NCT07428902

NCT07428902 Effects Of French Method With/Without Brace In Clubfoot Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07428902
Status Recruiting
Phase
Sponsor Riphah International University
Condition Club Foot
Study Type INTERVENTIONAL
Enrollment 18 participants
Start Date 2025-10-28
Primary Completion 2026-02-20

Eligibility & Interventions

Sex All sexes
Min Age 1 Day
Max Age 12 Months
Study Type INTERVENTIONAL
Interventions
French method and Foot Abduction BraceFrench Method only

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 18 participants in total. It began in 2025-10-28 with a primary completion date of 2026-02-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The current study will be a randomized control trial. Data will be collected from the Pakistan Society for the Rehabilitation of the Disabled, Lahore (PSRD) and the Children Hospital and Institute of Child Health, Lahore. The study will include 18 patients, equally divided into two groups and randomly allocated. Inclusion criteria will be children aged 0 to 12 months diagnosed with CTEV of either gender. Patients with neurological conditions, other orthopedic issues, previous surgical history related to the foot, severe systemic disorders, or neuromuscular disorders will be excluded from the study. The experimental group will receive the French method along with a foot abduction brace, while the control group will receive only the French method without the brace. Outcomes to be analyzed will include foot position, severity of deformity, and functional mobility. Data collection will occur before and after the intervention, utilizing clinical assessments for foot position, the Pirani score for severity of deformity, and standardized mobility assessments. Data will be analyzed using SPSS version 23.00.

Eligibility Criteria

Inclusion Criteria: * Patients under 12 months of age with clubfeet. * All patients without previous clubfoot surgery were included. * Children who have not received any prior corrective treatment or bracing for CTEV. Exclusion Criteria: * Patients with prior clubfoot surgery were excluded. * Non-idiopathic cases (patients with underlying conditions) typically did not respond well to the nonoperative interventions and were less likely to be included for purely nonoperative treatment.

Contact & Investigator

Central Contact

IMRAN AMJAD, PhD

✉ imran.amjad@riphah.edu.pk

📞 9233224390125

Principal Investigator

Shama Khizar, MSPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07428902 clinical trial?

This trial is open to participants of all sexes, aged 1 Day or older, up to 12 Months, studying Club Foot. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07428902 currently recruiting?

Yes, NCT07428902 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07428902 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07428902 clinical trial?

NCT07428902 is sponsored by Riphah International University. The principal investigator is Shama Khizar, MSPT at Riphah International University. The trial plans to enroll 18 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology